Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Cited by (1,077)

Items 901–1,000 of 1,077

1. Application of microencapsulation for the safe delivery of green tea polyphenols in food systems: Review and recent advances
   Awa Fanny Massounga Bora, Shaojie Ma, Xiaodong Li, Lu Liu · 2017 · Food Research International
2. The Chemical Neurobiology of Carbohydrates
   Heather E. Murrey, Linda C. Hsieh‐Wilson · 2008 · Chemical Reviews
3. Computational approaches to determine drug solubility
   Bernard Faller, Peter Ertl · 2007 · Advanced Drug Delivery Reviews
4. High-throughput drug discovery: What can we expect from HTS?
   Philip M. Gribbon, Sewing Andreas · 2005 · Drug Discovery Today
5. High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery
   Mary Lynn Baniecki, Dyann F. Wirth, Jon Clardy · 2006 · Antimicrobial Agents and Chemotherapy
6. Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
   Natalie K. Boyd, Chengwen Teng, Christopher Raymond Frei · 2021 · Frontiers in Cellular and Infection Microbiology
7. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria
   Imane Abdelli, Faiçal Hassani, Sohayb Bekkal Brikci, Saïd Ghalem · 2020 · Journal of Biomolecular Structure and Dynamics
8. New insights from structural biology into the druggability of G protein-coupled receptors
   Jonathan S. Mason, Andrea Bortolato, Miles Congreve, Fiona H. Marshall · 2012 · Trends in Pharmacological Sciences
9. The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis
   Susan Wyllie, Stephen Patterson, Laste Stojanovski, Frederick R. C. Simeons, Suzanne Norval, Robert Kime, Kevin D. Read, Alan H. Fairlamb · 2012 · Science Translational Medicine
10. Navigating structure–activity landscapes
    Jürgen Bajorath, Lisa Peltason, Mathias J. Wawer, Rajarshi Guha, Michael S. Lajiness, John H. Van Drie · 2009 · Drug Discovery Today
11. Exploring Chemical Information in PubChem
    Sunghwan Kim · 2021 · Current Protocols
12. Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90
    Maria Vilenchik, David B. Solit, Andrea Basso, Henri Huezo, Brian S. Lucas, Huazhong He, Neal X. Rosen, Claudia Patricia Spampinato, Paul L. Modrich, Gabriela Chiosis · 2004 · Chemistry & Biology
13. Prediction of intestinal absorption: comparative assessment of gastroplus™ and idea™
    Parrott, Neil, Lavé, Thierry · 2002 · European Journal of Pharmaceutical Sciences
14. Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell Culture
    Shawn C. Owen, Allison K. Doak, Pascal Wassam, Molly Sandra Shoichet, Brian K. Shoichet · 2012 · ACS Chemical Biology
15. Biopharmaceutics and pharmacokinetics in drug research
    Ramesh Panchagnula · 2000 · International Journal of Pharmaceutics
16. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques
    Dirk Jan van Drooge, Wouter L.J. Hinrichs, Marinella R. Visser, Henderik Willem Frijlink · 2006 · International Journal of Pharmaceutics
17. Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients
    Conan K. L. Wang, Susan E. Northfield, Barbara Colless, Stephanie Chaousis, Ingrid A. Edwards, Rink‐Jan Lohman, Daniel S. Nielsen, Christina I. Schroeder, Spiros I. Liras, David A. Price et al. · 2014 · Proceedings of the National Academy of Sciences
18. Fragment Based Drug Design: From Experimental to Computational Approaches
    Ashutosh Kumar, Arnout R. D. Voet, Kam Y. J. Zhang · 2012 · Current Medicinal Chemistry
19. Rosmarinic Acid–Human Pharmacokinetics and Health Benefits
    Maja Hitl, Nebojša Kladar, Neda Gavarić, Biljana N. Božin · 2020 · Planta Medica
20. Green Tea and Cancer Prevention
    Chung Shu Yang, Xin Wang · 2010 · Nutrition and Cancer
21. Arginine Topology Controls Escape of Minimally Cationic Proteins from Early Endosomes to the Cytoplasm
    Jacob Appelbaum, Jonathan R. LaRochelle, Betsy A. Smith, Daniel M. Balkin, Justin M. Holub, Alanna Schepartz · 2012 · Chemistry & Biology
22. Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options
    Bruce J. Aungst · 2016 · Journal of Pharmaceutical Sciences
23. Fundamental aspects of DMPK optimization of targeted protein degraders
    Carina Cantrill, Prasoon Chaturvedi, Caroline Rynn, Jeannine Petrig Schaffland, Isabelle Walter, Matthias Wittwer · 2020 · Drug Discovery Today
24. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs
    Nebih Lolak, Süleyman Akocak, Cüneyt Türkeş, Parham Taslımı, Mesut Işık, Şükrü Beydemir, İlhami Gülçın, Mustafa Durgun · 2020 · Bioorganic Chemistry
25. Simple vertebrate models for chemical genetics and drug discovery screens: Lessons from zebrafish and Xenopus
    Grant N. Wheeler, André W. Brändli · 2009 · Developmental Dynamics
26. The road map to oral bioavailability: an industrial perspective
    V. Hayden Thomas, Shobha Bhattachar, Linda Hitchingham, Philip Zocharski, Maryanne Naath, Narayanan Surendran, Chad L. Stoner, Ayman F. El‐Kattan · 2006 · Expert Opinion on Drug Metabolism & Toxicology
27. Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies Multiple Blood-Pressure-Related Loci
    Vinicius Tragante, Michael R. Barnes, Santhi K. Ganesh, Matthew Bruce Lanktree, Wei Guo, Nora Franceschini, Erin N. Smith, Toby Johnson, Michael Vaclav Holmes, Sandosh Padmanabhan et al. · 2014 · The American Journal of Human Genetics
28. Virtual screening for the discovery of bioactive natural products
    Judith Maria Rollinger, Hermann Stuppner, Thierry Langer · 2007 · Birkhäuser Basel eBooks
29. Emerging classes of protein–protein interaction inhibitors and new tools for their development
    Len Pagliaro, Jakob Felding, Karine Audouze, Søren Jensby Nielsen, Robert B Terry, Christian Krog-Jensen, Steven Butcher · 2004 · Current Opinion in Chemical Biology
30. Novel technologies for virtual screening
    Thomas Lengauer, Christian Lemmen, Matthias Rarey, Marc Zimmermann · 2004 · Drug Discovery Today
31. Scaffold composition and biological relevance of screening libraries
    Anang A. Shelat, Rodney Kiplin Guy · 2007 · Nature Chemical Biology
32. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis
    Lise‐Lotte Gundersen, Colin Charnock, Ayele H. Negussie, Frode Rise, Solomon Teklu · 2006 · European Journal of Pharmaceutical Sciences
33. A Comparative Study on the Constitutive Properties of Marketed Pesticides
    Ge‐Fei Hao, Qingjian Dong, Guang‐Fu Yang · 2011 · Molecular Informatics
34. Tackling Drought Stress: RECEPTOR-LIKE KINASES Present New Approaches
    Alex Marshall, Reidunn B. Aalen, Dominique Audenaert, Tom Beeckman, Martin R. Broadley, Melinka A. Butenko, Ana I. Caño‐Delgado, Sacco C. de Vries, Thomas Dresselhaus, Georg Felix et al. · 2012 · The Plant Cell
35. Computational design of peptide ligands
    Peter Vanhee, Almer M. van der Sloot, Erik Verschueren, Luis G. Serrano, Frédéric Rousseau, Joost W. H. Schymkowitz · 2011 · Trends in biotechnology
36. Qualitative prediction of blood–brain barrier permeability on a large and refined dataset
    Markus Muehlbacher, Gudrun Maria Spitzer, Klaus Roman Liedl, Johannes Kornhuber · 2011 · Journal of Computer-Aided Molecular Design
37. G4LDB: a database for discovering and studying G-quadruplex ligands
    Qian Li, Junfeng Xiang, Qianfan Yang, Hongxia Sun, Aijiao Guan, Yalin Tang · 2012 · Nucleic Acids Research
38. The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity
    Urban Košak, Boris Brus, Damijan Knez, Simon Žakelj, Jurij Trontelj, Anja Hafner Pišlar, Roman Šink, Marko Jukič, Marko Živin, Adrian Podkowa et al. · 2017 · Journal of Medicinal Chemistry
39. Fragment screening: an introduction
    Andrew R. Leach, Michael M. Hann, Jeremy Nicholas Burrows, Ed Griffen · 2006 · Molecular BioSystems
40. Mechanistic and functional differentiation of tapentadol and tramadol
    Robert B. Raffa, Helmut Buschmann, Thomas Christoph, Gary M. Eichenbaum, Werner Englberger, Christopher M. Flores, Torsten Hertrampf, Babette Y. Kögel, Klaus Schiene, Wolfgang Straßburger et al. · 2012 · Expert Opinion on Pharmacotherapy
41. Chemogenomic approaches to drug discovery
    Paul R. Caron, Michael D. Mullican, Robert D. Mashal, Keith P. Wilson, Michael S. S. Su, Mark A. Murcko · 2001 · Current Opinion in Chemical Biology
42. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets
    Donald M. Coen, Priscilla A. Schaffer · 2003 · Nature Reviews Drug Discovery
43. Peracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-Gallate
    Joshua D. Lambert, Shengmin Sang, Jungil Hong, Seok-Joo Kwon, Mao‐Jung Lee, Chi‐Tang Ho, Chung Shu Yang · 2006 · Drug Metabolism and Disposition
44. Plasmepsins as potential targets for new antimalarial therapy
    Karolina Ersmark, B. Samuelsson, A. Hallberg · 2006 · Medicinal research reviews (Print)
45. Protein Tyrosine Phosphatases: Structure, Function, and Implication in Human Disease
    Lutz Tautz, David Critton, Stefan Grotegut · 2013 · Methods in molecular biology
46. Prodrug Strategies for Enhancing the Percutaneous Absorption of Drugs
    David D. N’Da · 2014 · Molecules
47. Neurosteroids as regenerative agents in the brain: therapeutic implications
    Roberta Dı́az Brinton · 2013 · Nature Reviews Endocrinology
48. The importance of indole and azaindole scaffold in the development of antitumor agents
    Yu Kyeong Han, Wei Dong, Qunqun Guo, Xiufen Li, Longjiang Huang · 2020 · European Journal of Medicinal Chemistry
49. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering
    Christoph Loschen, Andreas Klamt · 2015 · Journal of Pharmacy and Pharmacology
50. Prediction and Classification of Drug Toxicity Using Probabilistic Modeling of Temporal Metabolic Data: The Consortium on Metabonomic Toxicology Screening Approach
    Timothy M. D. Ebbels, Hector C. Keun, Olaf P. Beckonert, Mary E. Bollard, John C. Lindon, Elaine C. Holmes, Jeremy Kirk Nicholson · 2007 · Journal of Proteome Research
51. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design
    Roger Vandecruys, Jef Peeters, Geert Verreck, Marcus Eli Brewster · 2007 · International Journal of Pharmaceutics
52. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation
    Soumya S. Ray, Richard J. Nowak, Robert H. Brown, Peter T. Lansbury · 2005 · Proceedings of the National Academy of Sciences
53. Chloramphenicol Derivatives as Antibacterial and Anticancer Agents: Historic Problems and Current Solutions
    George P. Dinos, Constantinos M. Athanassopoulos, Dionissia A. Missiri, Panagiota C. Giannopoulou, Ioannis A. Vlachogiannis, Georgios E. Papadopoulos, Dionissios A. Papaioannou, Dimitrios L. Kalpaxis · 2016 · Antibiotics
54. Orally Active Peptides: Is There a Magic Bullet?
    Andreas F. B. Räder, Michael Weinmüller, Florian Reichart, Adi Schumacher‐Klinger, Shira Merzbach, Chaim Gilon, Amnon Hoffman, Horst Kessler · 2018 · Angewandte Chemie International Edition
55. Machine Learning on DNA-Encoded Libraries: A New Paradigm for Hit Finding
    Kevin McCloskey, Eric A. Sigel, Steven M. Kearnes, Ling Xue, Xia Tian, Dennis Moccia, Diana Gikunju, Sana Bazzaz, Betty Chan, Matthew Clark et al. · 2020 · Journal of Medicinal Chemistry
56. Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies
    Paul D. Leeson, A. Patrícia Bento, Anna Gaulton, Anne Hersey, Emma Jayne Manners, Chris J. Radoux, Andrew R. Leach · 2021 · Journal of Medicinal Chemistry
57. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking
    Matthieu Schapira, Bruce M. Raaka, Sharmistha Das, Fan Li, Maxim M. Totrov, Zhiguo Zhou, Stephen R. Wilson, Ruben A Abagyan, Herbert H. Samuels · 2003 · Proceedings of the National Academy of Sciences
58. Efficient exploration of chemical space by fragment-based screening
    Richard J. Hall, Paul N. Mortenson, Christopher W. Murray · 2014 · Progress in Biophysics and Molecular Biology
59. Integrating Structure-Based and Ligand-Based Approaches for Computational Drug Design
    Gregory L Wilson, Markus A. Lill · 2011 · Future Medicinal Chemistry
60. Preclinical formulations for discovery and toxicology: physicochemical challenges
    Seshadri Neervannan · 2006 · Expert Opinion on Drug Metabolism & Toxicology
61. Hybrid Density Functional Methods Empirically Optimized for the Computation of 13 C and 1 H Chemical Shifts in Chloroform Solution
    Keith W. Wiitala, Thomas R. Hoye, Christopher J. Cramer · 2006 · Journal of Chemical Theory and Computation
62. Limitations and lessons in the use of X-ray structural information in drug design
    Andrew M. Davis, Stephen A. St-Gallay, Gerard J. Kleywegt · 2008 · Drug Discovery Today
63. Molecular Docking, Validation, Dynamics Simulations, and Pharmacokinetic Prediction of Phytochemicals Isolated From Croton dichogamus Against the HIV-1 Reverse Transcriptase
    Ermias Mergia Terefe, Arabinda Ghosh · 2022 · Bioinformatics and Biology Insights
64. Methods To Evaluate Biliary Excretion of Drugs in Humans: An Updated Review
    Giulia Ghibellini, Elaine M. Leslie, Kim L. R. Brouwer · 2006 · Molecular Pharmaceutics
65. Solubility and Permeation of Hydrogen Sulfide in Lipid Membranes
    Ernesto Cuevasanta, Ana Denicola, Beatriz Álvarez, Matías N. Möller · 2012 · PLoS ONE
66. Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery
    Alex Bunker, Tomasz Róg · 2020 · Frontiers in Molecular Biosciences
67. Functional Role of P-Glycoprotein in Limiting Intestinal Absorption of Drugs: Contribution of Passive Permeability to P-Glycoprotein Mediated Efflux Transport
    Manthena V. S. Varma, Sateesh Khandavilli, Ramesh Panchagnula · 2004 · Molecular Pharmaceutics
68. Endocrine Disruptome—An Open Source Prediction Tool for Assessing Endocrine Disruption Potential through Nuclear Receptor Binding
    Katra Kolšek, Janez Mavri, Marija Sollner Dolenc, Stanislav Gobec, Samo Turk · 2014 · Journal of Chemical Information and Modeling
69. Design and Development of Peptides and Peptide Mimetics as Antagonists for Therapeutic Intervention
    Jody M. Mason · 2010 · Future Medicinal Chemistry
70. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations
    Balázs Démuth, Zsombor Kristóf Nagy, Attila Balogh, Tamás Vígh, György Marosi, Geert Verreck, Ivo Van Assche, Marcus Eli Brewster · 2015 · International Journal of Pharmaceutics
71. Species Independence in Brain Tissue Binding Using Brain Homogenates
    Li Di, John P. Umland, George Chang, Youping Huang, Zhen Lin, Dennis O. Scott, Matthew D. Troutman, Theodore E. Liston · 2011 · Drug Metabolism and Disposition
72. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement
    Sharad B. Murdande, Michael Jon Pikal, Ravi M. Shanker, Robin H. Bogner · 2010 · Pharmaceutical Development and Technology
73. Delivery of Tea Polyphenols to the Oral Cavity by Green Tea Leaves and Black Tea Extract
    Mao‐Jung Lee, Joshua D. Lambert, Saileta Prabhu, Xiaofeng Meng, Hong Lu, Pius P. Maliakal, Chi‐Tang Ho, Chung Shu Yang · 2004 · Cancer Epidemiology Biomarkers & Prevention
74. Strong and Weak Hydrogen Bonds in Protein–Ligand Recognition
    Gopalakrishnan Bulusu, Gautam Radhakrishna Desiraju · 2019 · Journal of the Indian Institute of Science
75. Advanced drug delivery 2020 and beyond: Perspectives on the future
    You Han Bae, Kinam Park · 2020 · Advanced Drug Delivery Reviews
76. Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications
    Laura Goracci, Jenny Desantis, Aurora Valeri, Beatrice Castellani, Michela Eleuteri, Gabriele Cruciani · 2020 · Journal of Medicinal Chemistry
77. Antioxidants in Plants: A Valorization Potential Emphasizing the Need for the Conservation of Plant Biodiversity in Cuba
    Gabriel Llauradó Maury, Daniel Méndez, Sophie Hendrix, Júlio Cesar Escalona Arranz, Yilan Fung Boix, Ania Ochoa Pacheco, Jesús García Díaz, Humberto J. Morris, Albys Ferrer Dubois, Elizabeth Isaac Alemán et al. · 2020 · Antioxidants
78. New chalcone derivatives as potential antimicrobial and antioxidant agent
    Emelda N. Okolo, David Izuchukwu Ugwu, Benjamin Ebere Ezema, Joseph Chinedum Ndefo, Florence Uchenna Eze, Chidimma Grace Ezema, James Anayochukwu Ezugwu, Oguejiofo Theophilus Ujam · 2021 · Scientific Reports
79. Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
    Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, Chris de Graaf, Jens Carlsson · 2021 · Pharmacological Reviews
80. Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation
    Mengwei Zhang, Shumao Cui, Bingyong Mao, Qiuxiang Zhang, Jianxin Zhao, Hao Zhang, Xin Tang, Wei Chen · 2022 · Critical Reviews in Food Science and Nutrition
81. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity
    Siyun Yang, Supratik Kar · 2023 · Artificial Intelligence Chemistry
82. Pharmacokinetics and metabolism in early drug discovery
    Dennis A. Smith, H. Van De Waterbeemd · 1999 · Current Opinion in Chemical Biology
83. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective
    Hongyu Zhao · 2006 · Drug Discovery Today
84. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: Design, synthesis and evaluation as potential anti-inflammatory agents
    Ghaneya Sayed Hassan, Sahar M. Abou‐Seri, Gehan M. Kamel, Mamdouh M. Ali · 2014 · European Journal of Medicinal Chemistry
85. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology
    Anshul Agarwal, YURI M. LVOV, Rishikesh Sawant, Vladimir P. Torchilin · 2008 · Journal of Controlled Release
86. The influence of the 'organizational factor' on compound quality in drug discovery
    Paul D. Leeson, Stephen A. St-Gallay · 2011 · Nature Reviews Drug Discovery
87. Developing degraders: principles and perspectives on design and chemical space
    Hannah J. Maple, Nat Clayden, Anne Baron, Callum Stacey, Robert L. Felix · 2019 · MedChemComm
88. Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models
    Chung-Han Hsieh, Li Li, Roeland Vanhauwaert, Kong T. Nguyen, Mary D. Davis, Guojun Bu, Zbigniew K. Wszołek, Xinnan Wang · 2019 · Cell Metabolism
89. A dual diffusion model enables 3D molecule generation and lead optimization based on target pockets
    Lei Huang, Tingyang Xu, Yang Yu, Peilin Zhao, Xingjian Chen, Jing Han, Zhi Xie, Hailong Li, Wenge Zhong, Ka‐Chun Wong et al. · 2024 · Nature Communications
90. Oral Bioavailability Enhancement of Exemestane from Self-Microemulsifying Drug Delivery System (SMEDDS)
    Ajeet Kumar Singh, Akash Chaurasiya, Anshumali Awasthi, Gautam Mishra, Dinesh Prasad Asati, Roop Kishan Khar, Rama Mukherjee · 2009 · AAPS PharmSciTech
91. Pulmonary Absorption Rate and Bioavailability of Drugs in Vivo in Rats: Structure–Absorption Relationships and Physicochemical Profiling of Inhaled Drugs
    Ann Tronde, Bo Nordén, Hans Marchner, Anna‐Karin Wendel, Hans Lennernäs, Ursula Hultkvist Bengtsson · 2003 · Journal of Pharmaceutical Sciences
92. High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells
    Parvinder Hothi, Timothy J. Martins, Liping Chen, Loic P. Deleyrolle, Jae‐Geun Yoon, Brent A. Reynolds, Greg Foltz · 2012 · Oncotarget
93. A single molecular descriptor to predict solution behavior of therapeutic antibodies
    Jonathan S. Kingsbury, Amandeep Saini, Sarah Marie Auclair, Li Fu, Michaela M. Lantz, Kevin T. Halloran, Cesar Calero‐Rubio, Walter J Schwenger, Christian Y. Airiau, Jifeng Zhang et al. · 2020 · Science Advances
94. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy
    Maimoona Qindeel, Muhammad Hameed Ullah, Fakhar ud Din, Naveed Ahmed, Asim ur Rehman · 2020 · Journal of Controlled Release
95. Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
    C. Glenn Begley, Mark R. Ashton, Jonathan B. Baell, Michael D. Bettess, Michael Paul Brown, Brett Anthony Carter, William N. Charman, Christopher Davis, Simon Fisher, Ian Hector Frazer et al. · 2021 · Science Translational Medicine
96. Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential
    Firda Juhairiyah, Elizabeth C. M. de Lange · 2021 · The AAPS Journal
97. Delivery of RNA Therapeutics: The Great Endosomal Escape!
    Steven F. Dowdy, Ryan L. Setten, Xian-Shu Cui, Satish G. Jadhav · 2022 · Nucleic Acid Therapeutics
98. Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials
    Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F. P. Jake Haeckl, Julian D. Hegemann, Thomas Hesterkamp, Anna K. H. Hirsch, Peter Hammann, Rolf Müller · 2022 · EMBO Reports
99. Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of Micrococcus luteus with secondary metabolites from Bacillus licheniformis recognized by genome mining approach
    Zabin K. Bagewadi, T. M. Yunus Khan, Bhavya Somalapura Gangadharappa, Ankita Kamalapurkar, Shaik Mohamed Shamsudeen, Deepak A. Yaraguppi · 2023 · Saudi Journal of Biological Sciences
100. Application advances of deep learning methods for de novo drug design and molecular dynamics simulation
     Bai, Qifeng, Liu, Shuo, Tian, Yanan, Xu, Tingyang, Banegas‐Luna, Antonio Jesús, Pérez‐Sánchez, Horacio, Huang, Junzhou, Liu, Huanxiang, Yao, Xiaojun · 2022 · WIREs Computational Molecular Science